Alcoa
Search documents
Inside Alcoa's Latest Earnings
Forbes· 2026-01-30 14:07
Financial Performance - Alcoa reported revenues of approximately $3.4 billion, showing a robust sequential increase driven by elevated aluminum and alumina prices along with enhanced shipment volumes [2] - Adjusted earnings were about $1.25 per share, surpassing market predictions, indicating a return to solid profitability after a volatile previous cycle [2] - Operating cash flow improved significantly, strengthening Alcoa's balance sheet and liquidity as it approaches 2026 [2] Operational Highlights - The quarter saw increased aluminum production as smelters operated at higher utilization levels, and alumina production benefited from fewer interruptions and improved cost management [5] - Management highlighted record output at various facilities, demonstrating the business's leverage when pricing and operations align [5] - Improvements helped mitigate persistent energy costs and inflationary pressures that have been significant concerns for investors [5] Stock Performance - Alcoa shares have shown strong gains over the past year, outperforming broader materials indices as investors anticipated higher earnings potential and increasing free cash flow [6] - The immediate market response to the recent earnings report was subdued, indicating that much of the favorable news had already been factored into the stock price [6] - Some profit-taking occurred as investors shifted focus from the recent quarter to expectations around margins and volumes in the upcoming quarters [6] Future Outlook - Alcoa reaffirmed expectations for stable aluminum and alumina production in 2026, with volumes generally in line with current run rates [7] - The company anticipates high capital expenditures to sustain operations, pursue decarbonization initiatives, and undertake selective growth projects [7] - Management acknowledged that specific assets, including major smelter restarts, will impact near-term earnings before becoming accretive later in the cycle [7] Investment Thesis - The investment thesis for Alcoa now hinges on execution and the commodity landscape rather than solely on recovery [8] - If aluminum prices remain stable and cost pressures diminish, the company's operating leverage could lead to another phase of earnings growth [8] - Alcoa's stock is currently valued at $64, approximately 8% above the current market price, reflecting a genuine turnaround [8]
Buy These 5 Low-Leverage Stocks as S&P 500 Touches Record Mark
ZACKS· 2026-01-29 14:36
Market Overview - Wall Street achieved a historic milestone with the S&P 500 reaching the 7,000 mark for the first time, driven by the Federal Reserve's decision to maintain steady interest rates, indicating solid economic expansion [1][10] - Investor confidence was bolstered by the Fed's assessment of a stabilizing labor market, despite the index ending the session with little change [1] Investment Strategy - The current market conditions are likely to enhance the attractiveness of low-leverage stocks, as investors may prioritize financial resilience and capital preservation over aggressive growth strategies [2] - Recommended companies with low leverage include ThyssenKrupp (TKAMY), Alcoa Corp. (AA), Coeur Mining (CDE), FirstSun Capital Bancorp (FSUN), and TechnipFMC (FTI), which are seen as safer options during market volatility [2][10] Low-Leverage Stocks - Leverage in finance refers to borrowing capital to operate and expand businesses, typically through debt financing, which can pose risks if not managed properly [4][5] - Companies with low debt levels are generally less risky and can provide more stable returns, especially during economic downturns [6][11] - The debt-to-equity ratio is a key metric for assessing a company's financial risk, with lower ratios indicating better solvency [7] Company Highlights - **ThyssenKrupp (TKAMY)**: Recognized for its environmental efforts, the company expects a 2.1% increase in fiscal 2026 sales and a 24.1% rise in earnings, holding a Zacks Rank 1 [15][16] - **Alcoa (AA)**: Despite a 1.1% decline in revenues, adjusted EPS surged by 21.2%, with a projected 8.5% revenue increase and a 34% earnings growth for 2026, also holding a Zacks Rank 1 [17][18] - **Coeur Mining (CDE)**: The company is undertaking its largest exploration campaign since 2012, with a projected 30.2% revenue increase and a 116.9% earnings growth for 2026, holding a Zacks Rank 1 [19][20] - **FirstSun Capital Bancorp (FSUN)**: Reported a 10.5% year-over-year increase in adjusted EPS and expects a 61.6% revenue increase for 2026, holding a Zacks Rank 1 [21][22] - **TechnipFMC (FTI)**: Awarded a significant contract by BP, with a projected 9.6% revenue increase and a long-term earnings growth rate of 18.8%, holding a Zacks Rank 2 [23][24]
Nationally Recognized Plaintiffs' Law Firm Glancy Prongay & Murray LLP Announces Name Change To Glancy Prongay Wolke & Rotter LLP
Businesswire· 2026-01-28 21:28
LOS ANGELES--(BUSINESS WIRE)--Leading plaintiffs' class action law firm Glancy Prongay & Murray LLP today announced that the Firm is changing its name to Glancy Prongay Wolke & Rotter LLP. The change reflects the substantial contributions that partners Kara Wolke, co-chair of the Firm's securities litigation group, and Jonathan Rotter, chair of the Firm's antitrust, consumer protection, and privacy groups, have made to the success of the Firm and the results that they have achieved for. ...
Check Out What Whales Are Doing With Alcoa - Alcoa (NYSE:AA)
Benzinga· 2026-01-27 20:00
Core Insights - High-rolling investors are taking a bearish position on Alcoa (NYSE:AA), indicating potential insider knowledge or market sentiment shifts [1] - The sentiment among major traders is predominantly bearish, with 63% of options identified being bearish compared to 26% bullish [2] Options Activity - A total of 19 options trades for Alcoa were identified, with one put option valued at $29,875 and 18 call options totaling $2,321,041 [2] - The significant volume and open interest suggest that major players are targeting a price range for Alcoa between $35.0 and $70.0 over the past quarter [3][4] Recent Trading Metrics - The trading volume for Alcoa stands at 4,894,144, with the stock price currently at $58.2, reflecting a 1.5% increase [10] - Analysts have provided an average target price of $62.25 for Alcoa, with varying ratings from different firms, including a downgrade from Morgan Stanley to Equal-Weight with a target of $64 and a downgrade from JP Morgan to Underweight with a target of $50 [9][10] Company Overview - Alcoa is a vertically integrated aluminum company, recognized as the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer [8] - The company has a historical significance as the first mass producer of aluminum and has undergone strategic changes, including the spin-off of its automotive and aerospace segment in 2016 [8]
Aclaris Therapeutics' Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA)
Globenewswire· 2026-01-27 11:55
Core Insights - Aclaris Therapeutics announced positive preclinical results for ATI-2138, a potent ITK/JAK3 inhibitor, showing significant hair regrowth in a murine model of severe alopecia areata compared to ritlecitinib [1][2][3] Group 1: Drug Efficacy - ATI-2138 demonstrated rapid and near-complete hair regrowth in mice, achieving 87% regrowth at week 4 and 93% at week 6, compared to 48% and 78% for ritlecitinib respectively [3] - The study utilized a reversal model of alopecia universalis, indicating that ATI-2138 is effective even in older and more difficult-to-treat mice [2][3] Group 2: Mechanism of Action - ATI-2138 acts as a dual inhibitor of ITK and JAK3, affecting T cell receptor signaling and regulating T cell expansion and activation [2][7] - The drug is highly selective, being over 1,000-fold more potent against ITK and JAK3 than other JAK isoforms, which may lead to a strong anti-inflammatory response [2][7] Group 3: Future Development - Aclaris plans to initiate a Phase 2b trial for ATI-2138 in the first half of 2026, exploring its potential in treating various inflammatory and autoimmune diseases, including alopecias [6][10] - The company is assessing additional indications for ATI-2138, leveraging its unique pharmacological profile [6][10] Group 4: Company Overview - Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel treatments for immuno-inflammatory diseases, with a robust R&D pipeline [8] - The company aims to address unmet medical needs in patients suffering from conditions that lack satisfactory treatment options [8]
Alcoa's Post-Q4 Earnings Dip Offers A Buying Opportunity
Seeking Alpha· 2026-01-26 12:45
Group 1 - The article discusses the potential benefits of subscribing to Beyond the Wall Investing for access to high-quality equity research reports, which can save investors thousands of dollars annually [1] - Alcoa Corporation (AA) stock has been under review for about 9 months, with a previous "Buy" rating maintained despite a continued correction in the stock price [1] - Oakoff Investments, a personal portfolio manager and quantitative research analyst, leads the investing group Beyond the Wall Investing, offering features such as a fundamentals-based portfolio and weekly analysis [1]
Alcoa Corporation (NYSE:AA) Maintains Strong Position in Aluminum Industry
Financial Modeling Prep· 2026-01-23 18:06
Core Viewpoint - Alcoa Corporation is a leading player in the aluminum industry, with a strong market position and positive financial performance indicators, despite facing slight revenue declines [1][6]. Financial Performance - Alcoa reported Q4 2025 revenue of $3.45 billion, a decrease of 1.1% year-over-year, but exceeded the Zacks Consensus Estimate of $3.24 billion, resulting in a positive surprise of 6.34% [3][6]. - The company's earnings per share (EPS) for Q4 2025 were $1.26, up from $1.04 the previous year, and significantly above the consensus estimate of $0.95, delivering a surprise of 32.63% [4][6]. - Alcoa's fourth-quarter profit increased to $226 million, compared to $202 million in the same period the previous year, driven by gains in alumina and aluminum sales [5][6]. Market Position and Ratings - B. Riley maintained a "Buy" rating for Alcoa and raised its price target from $44 to $78, indicating confidence in the company's future performance [2][6]. - The current stock price of Alcoa is $63.14, reflecting a slight decrease of 1.14%, with a market capitalization of approximately $16.35 billion [5].
Alcoa vs. Ryerson: Which Aluminum Stock Should You Bet On?
ZACKS· 2026-01-23 16:40
Core Insights - Alcoa Corporation (AA) and Ryerson Holding Corporation (RYI) are key players in the aluminum sector, with high aluminum prices driven by global economic uncertainties and trade tensions [2] - The demand for aluminum is increasing due to its applications in electric vehicles, recycled materials, and the aerospace industry [3] Alcoa Corporation (AA) - Alcoa benefits from increased aluminum demand and a 50% tariff on imported aluminum, which has raised domestic prices [5] - In 2025, Alcoa's Aluminum segment production rose 5% year-over-year to 2,319 kilometric tons, with third-party revenues increasing by 15.6% [6][7] - The Alumina segment faced a 3.9% production decline to 9,640 kilometric tons in 2025, but is expected to recover in 2026 [8] - Alcoa's acquisition of Alumina Limited in August 2024 enhances its position in the market and is expected to create long-term value [9] - The Zacks Consensus Estimate for Alcoa's 2026 sales indicates a 7% growth, with EPS expected to rise by 18.3% [16] - Alcoa's stock has increased by 68.7% over the past year, and it trades at a forward P/E ratio of 13.16X, below its three-year median [20][22] Ryerson Holding Corporation (RYI) - Ryerson's diversified structure allows it to offset weaknesses in certain markets with strengths in others, benefiting from increased infrastructure spending and reshoring [10] - In the first nine months of 2025, aluminum product line shipments remained stable at 143,000 tons, with revenues rising 7.7% to $868 million [12] - However, revenues from carbon steel and stainless steel product lines declined due to lower average selling prices [13] - RYI expects fourth-quarter net sales between $1.07 billion and $1.11 billion, with a projected decline in customer shipments [14] - Ryerson's long-term debt increased by 6.7% to $498.2 million, raising concerns about its financial health [15] - The Zacks Consensus Estimate for RYI's 2026 sales implies an 11.4% growth, but EPS is expected to rise significantly by 256.3% [18] - Ryerson's stock has gained 38.7% over the past year, but it trades at a higher forward P/E ratio of 22.23X compared to its three-year median [20][22] Investment Outlook - Alcoa's strong momentum in the aluminum segment and favorable valuation make it a more attractive investment compared to Ryerson, which faces challenges in manufacturing demand and high debt levels [22][23]
Alcoa expects $10/ton CBAM premium uplift in Europe for 2026 while advancing San Ciprián restart (NYSE:AA)
Seeking Alpha· 2026-01-23 02:47
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]
Alcoa Corporation 2025 Q4 - Results - Earnings Call Presentation (NYSE:AA) 2026-01-22
Seeking Alpha· 2026-01-23 02:01
Core Insights - The article emphasizes the importance of enabling Javascript and cookies in browsers to prevent access issues [1] Group 1 - The article suggests that users may face restrictions if ad-blockers are enabled, indicating a need for users to disable them for better access [1]